Search by Drug Name or NDC
NDC 00574-2042-30 LIDOCAINE AND PRILOCAINE 25; 25 mg/g; mg/g Details
LIDOCAINE AND PRILOCAINE 25; 25 mg/g; mg/g
LIDOCAINE AND PRILOCAINE is a TOPICAL CREAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis US LLC. The primary component is LIDOCAINE; PRILOCAINE.
Product Information
| NDC | 00574-2042 |
|---|---|
| Product ID | 0574-2042_31d53fc5-3004-41e1-a5af-cf6b8f4285a6 |
| Associated GPIs | |
| GCN Sequence Number | 035495 |
| GCN Sequence Number Description | lidocaine/prilocaine CREAM (G) 2.5 %-2.5% TOPICAL |
| HIC3 | Q5H |
| HIC3 Description | TOPICAL LOCAL ANESTHETICS |
| GCN | 05987 |
| HICL Sequence Number | 016196 |
| HICL Sequence Number Description | LIDOCAINE/PRILOCAINE |
| Brand/Generic | Generic |
| Proprietary Name | LIDOCAINE AND PRILOCAINE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lidocaine and Prilocaine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Active Ingredient Strength | 25; 25 |
| Active Ingredient Units | mg/g; mg/g |
| Substance Name | LIDOCAINE; PRILOCAINE |
| Labeler Name | Padagis US LLC |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212482 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00574-2042-30 (00574204230)
| NDC Package Code | 0574-2042-30 |
|---|---|
| Billing NDC | 00574204230 |
| Package | 1 TUBE in 1 CARTON (0574-2042-30) / 30 g in 1 TUBE |
| Marketing Start Date | 2022-12-20 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.33784 |
| Pricing Unit | GM |
| Effective Date | 2024-02-21 |
| NDC Description | LIDOCAINE-PRILOCAINE 2.5%-2.5% CREAM |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis